Upgrade to SI Premium - Free Trial

Wells Fargo Reiterates Overweight Rating on Eli Lilly (LLY), New Large-Cap Pharma Top Pick

August 20, 2024 5:54 AM
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $1,000.00 price target on Eli Lilly (NYSE: LLY).The analyst said ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments

Next Articles